Jerash Holdings (US) vs Lanvin
JRSH and LANV side by side, both in apparel and other finished products made from fabrics and similar materials. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How JRSH and LANV compare
Jerash Holdings (US) grew revenue faster over the last twelve months (26.6% versus −17.6% for Lanvin).
Jerash Holdings (US) keeps more of each dollar of sales as profit, with a net margin of 3.6% compared with −99.2% at Lanvin.
Jerash Holdings (US) pays a dividend yielding 2.7%; Lanvin does not pay one.
Jerash Holdings (US) scores higher on the StockData Score (15 against 0 for Lanvin), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | JRSH | LANV |
|---|---|---|
| Size and price | ||
| Market cap | $93.3M | – |
| Share price | $7.35 | $0.720 |
| Change, 1 year | 125% | −63.8% |
| Change, 5 years | −0.94% | −92.6% |
| Beta (5Y) | 0.36 | −0.02 |
| Employees | 6,300 | 2,066 |
| StockData Score | ||
| Total score | 15 (better) | 0 |
| Valuation score | 2 (better) | 0 |
| Growth score | 4 (better) | 0 |
| Performance score | 3 (better) | 0 |
| Health score | 3 (better) | 0 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 14.7× | – |
| P/S | 0.5× | – |
| P/B | 1.4× | – |
| EV/EBITDA | 7.4× | – |
| P/FCF | 20.2× | – |
| PEG | 1.18 | – |
| FCF yield | 4.9% | – |
| Fair value | $7.26 | – |
| Margin of safety | −1.2% | – |
| Growth | ||
| Revenue growth (TTM) | 26.6% (better) | −17.6% |
| Revenue growth, 5Y average | 13.0% (better) | 1.6% |
| Net income growth (TTM) | 960% | – |
| EPS growth (TTM) | 733% | – |
| EPS growth, 5Y average | −6.1% | – |
| Profitability | ||
| Gross margin | 17.2% | 58.2% (better) |
| Operating margin | 5.4% (better) | −96.3% |
| Net margin | 3.6% (better) | −99.2% |
| FCF margin | 2.5% | – |
| Return on equity | 10.1% | – |
| Return on invested capital | 16.0% (better) | −42.6% |
| Financial health | ||
| Interest coverage | 5.4× (better) | −6.5× |
| Current ratio | 3.12 (better) | 0.20 |
| Altman Z-score | 6.05 | – |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | 2.7% | – |
| Payout ratio | 38.5% | – |
| Years of dividend growth | 1 | – |
| Shareholder yield | 2.7% | – |
| Ownership | ||
| Held by institutions | 12.3% | – |
| Held by insiders | 0.04% | 72.4% |
| Insider net buying, 12 months | −$1.3K | – |
| Short interest, % of float | 0.31% | – |
Go deeper
- JRSH stock overview
- JRSH income statement
- JRSH valuation and score
- LANV stock overview
- LANV income statement
- LANV valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.